The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation
Open accessAbstract
Approaches to the measurement of lymphohematopoietic chimerism have evolved from laboratory research to important clinical tools. However, there has been no logical, consistent, and uniform set of recommendations for the measurement of chimerism in clinical transplantation. The National Marrow Donor Program and the International Bone Marrow Transplant Registry (IBMTR) sponsored a workshop to discuss the use of chimerism analysis after allogeneic transplantation. The workshop was organized in an effort to make reasonable recommendations regarding laboratory techniques, the types of specimens to be studied, and the frequency of analysis. The panel recommended the following guidelines: 1. Chimerism analysis should use sensitive, informative techniques. At present, short tandem repeats (STR) or variable number tandem repeats (VNTR) analysis is the approach most likely to give reproducible informative data. 2. Peripheral blood cells are generally more useful than bone marrow cells for chimerism analysis. 3. Lineage-specific chimerism should be considered the assay of choice in the setting of nonmyeloablative and reduced-intensity conditioning. 4. The use of T-cell depletion, nonmyeloablative or reduced-intensity conditioning, or novel graft-versus-host disease (GVHD) prophylactic regimens warrants chimerism analysis at 1, 3, 6, and 12 months, because interventions such as donor lymphocyte infusions may depend on chimerism status. 5. In nonmyeloablative transplantation, the early patterns of chimerism may predict either GVHD or graft loss. Therefore, more frequent (every 2-4 weeks) peripheral blood analysis may be warranted. 6. For nonmalignant disorders, chimerism generally should be measured 1, 2, and 3 months after transplantation. Interventions to enhance donor engraftment must be considered on a disease-specific basis in relation to concurrent GVHD and, ultimately, clinical rationale.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Hypervariable ‘minisatellite’ regions in human DNA
Jeffreys, A. J., Wilson, V., & Thein, S. L. (1985) · Nature · doi:10.1038/314067a0 · Cited by 3,741
Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., et al. (1998) · Blood · doi:10.1182/blood.v91.3.756 · Cited by 2,071
Giralt, S., Estey, E., Albitar, M., van Besien, K., Rondón, G., Anderlini, P., O'Brien, S., Khouri, I., Gajewski, J., Mehra, R., et al. (1997) · Blood · doi:10.1182/blood.v89.12.4531 · Cited by 1,138
Self-citationChilds, R., Chernoff, A., Contentin, N., Bahceci, E., Schrump, D., Leitman, S., Read, E. J., Tisdale, J., Dunbar, C., Linehan, W. M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009143431101 · Cited by 998
Self-citationChilds, R., Clave, E., Contentin, N., Jayasekera, D., Hensel, N., Leitman, S., Read, E. J., Carter, C., Bahceci, E., Young, N. S., et al. (1999) · Blood · doi:10.1182/blood.v94.9.3234 · Cited by 526
Self-citationJeffreys, A. J., Wilson, V., Neumann, R., & Keyte, J. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.23.10953 · Cited by 496
Microchimerism of maternal origin persists into adult life
Maloney, S., Smith, A., Furst, D. E., Myerson, D., Rupert, K., Evans, P. C., & Nelson, J. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6611 · Cited by 454
Sequence Analysis and Characterization of Stutter Products at the Tetranucleotide Repeat Locus VWA
Walsh, P. S., Fildes, N. J., & Reynolds, R. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.14.2807 · Cited by 411
Evans, P. C., Lambert, N., Maloney, S., Furst, D. E., Moore, J. M., & Nelson, J. L. (1999) · Blood · doi:10.1182/blood.v93.6.2033.406k18_2033_2037 · Cited by 393
Thiede, C., Florek, M., Bornhäuser, M., Ritter, M., Mohr, B., Brendel, C., Ehninger, G., & Neubauer, A. (1999) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701779 · Cited by 257
Spitzer, T. R., McAfee, S., Sackstein, R., Colby, C., Toh, H. C., Multani, P., Saidman, S., Weymouth, D., Preffer, F., Poliquin, C., et al. (2000) · Biology of Blood and Marrow Transplantation · doi:10.1016/s1083-8791(00)70056-5 · Cited by 247
Self-citationScharf, S., Smith, A., Hansen, J., McFarland, C., & Erlich, H. (1995) · Blood · doi:10.1182/blood.v85.7.1954.bloodjournal8571954 · Cited by 183
Pelot, M. R., Pearson, D. A., Swenson, K., Zhao, G., Sachs, J., Yang, Y.-G., & Sykes, M. (1999) · Biology of Blood and Marrow Transplantation · doi:10.1053/bbmt.1999.v5.pm10392959 · Cited by 171
Mackinnon, S., Barnett, L., Heller, G., & O'Reilly, R. (1994) · Blood · doi:10.1182/blood.v83.11.3409.3409 · Cited by 170
Self-citationMATHÉ, G., AMIEL, J. L., SCHWARZENBERG, L., CATTAN, A., SCHNEIDER, M., DE VRIES, M. J., TUBIANA, M., LALANNE, C., BINET, J. L., PAPIERNIK, M., et al. (1965) · Blood · doi:10.1182/blood.v25.2.179.179 · Cited by 166
Cited by
Baron, F., Baker, J. E., Storb, R., Gooley, T. A., Sandmaier, B. M., Maris, M. B., Maloney, D. G., Heimfeld, S., Oparin, D., Zellmer, E., et al. (2004) · Blood · doi:10.1182/blood-2004-04-1506 · Cited by 253
Navarro-Bailón, A., Carbonell, D., Escudero, A., Chicano, M., Muñiz, P., Suárez-González, J., Bailén, R., Oarbeascoa, G., Kwon, M., Díez-Martín, J. L., et al. (2020) · Genes · doi:10.3390/genes11090993 · Cited by 36
Metadata
- Authors
- Antin, J. H., Childs, R., Filipovich, A. H., Giralt, S., Mackinnon, S., Spitzer, T., & Weisdorf, D.
- Venue
- Biology of Blood and Marrow Transplantation
- Publisher
- Elsevier BV
- Published
- 2001-09
- Volume
- 7
- Issue
- 9
- Pages
- 473-485
- ISSN
- 1083-8791 (ISSN-L)
- OpenAlex
- W2082858272
- Cited by
- 266
- References
- 16
- FWCI
- 6.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.